Skip to main content
. Author manuscript; available in PMC: 2019 Oct 14.
Published in final edited form as: J Am Chem Soc. 2019 Sep 27;141(40):15737–15741. doi: 10.1021/jacs.9b07317

Figure 3.

Figure 3.

(a) In the primary screen, syn-BNP cyclic peptides were tested at 10 μg/mL in quadruplicates, and the results are shown as percent growth relative to DMSO controls for a Gram-positive bacterium (S. aureus), a Gram-negative bacterium (E. coli), a fungal pathogen (C. albicans), and a human cell line (HeLa). (b) Dose–response curves of HeLa cells measured with the MTT assay following exposure to each active syn-BNP cyclic peptide.